Central Nervous System Disease Drives Mortality in HER2+ Metastatic Breast Cancer Despite Longer Survival

Central Nervous System Disease Drives Mortality in HER2+ Metastatic Breast Cancer Despite Longer Survival

Patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC) with central nervous…

Continue Reading
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer | BMC Gastroenterology

Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer | BMC Gastroenterology

The GENERATE study provides a detailed description of patient characteristics, treatment patterns, HCRU and survival outcomes…

Continue Reading
CDSCO gives nod to AstraZeneca India’s drug for Gastric and HER2-Low Metastatic Breast cancer – Healthcare News

CDSCO gives nod to AstraZeneca India’s drug for Gastric and HER2-Low Metastatic Breast cancer – Healthcare News

AstraZeneca Pharma India Limited on Wednesday announced that it has received permission to import for sale…

Continue Reading
CDSCO gives nod to AstraZeneca India’s drug for Gastric and HER2-Low Metastatic Breast cancer – Healthcare News

CDSCO gives nod to AstraZeneca India’s drug for Gastric and HER2-Low Metastatic Breast cancer – Pharma News

AstraZeneca Pharma India Limited on Wednesday announced that it has received permission to import for sale…

Continue Reading